2nd Annual Conference on Vaccine Research (1999)

Sunday, March 28, 1999

Welcome and Introductions
William J. Martone, MD
National Foundation for Infectious Diseases
Introduction of Keynote Speaker
Peter L. Nara, DVM, PhD
Biological Mimetics, Inc.
International Society for Vaccines
Keynote Address
Keynote Address: Immune Memory and the Recall Response Peter C. Doherty, PhD
St. Jude's Children's Hospital
Symposium 1: Vaccines for Major World Diseases: AIDS, Malaria, Tuberculosis
Moderators:
Paul-Henri Lambert, MD
World Health Organization

Philip K. Russell, MD
The Johns Hopkins University School of Hygiene and Public Health

Introduction to Vaccines for Major World Diseases
Paul-Henri Lambert, MD
World Health Organization
Philip K. Russell, MD
The Johns Hopkins University School of Hygiene and Public Health
Biographical Tribute to the Career of Mary Lou Clements-Mann
Myron M. Levine, MD, DTPH
University of Maryland
Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences: Progress, Obstacles and Future Priorities in HIV Vaccine Development
Margaret I. (Peggy) Johnston, PhD
National Institutes of Health
Tribulation or Triumph: Are We Close to a Successful Malaria Vaccine?
Colonel W. Ripley Ballou, MD
Walter Reed Army Institute of Research
Reaping the Fruits of Biotechnology: Development of Better Tuberculosis Vaccines
Douglas B. Young, PhD
Imperial College School of Medicine
Submitted Presentations 1
Submitted Presentations 2
Symposium 2: Antigen Processing and Presentation
Moderators:
Brian W.J. Mahy, PhD, ScD
Centers for Disease Control and Prevention
Howard R. Six, MD
Pasteur Mérieux Connaught
Molecular Mechanisms of MHC Class I-Restricted Antigen Processing
Peter Cresswell, PhD
Howard Hughes Medical Institute
Yale University School of Medicine
Immune Surveillance of Viral Infections
Kenneth L. Rock, MD
University of Massachusetts Medical School
Modulation of Proteasome Structure and Function for Antigen Processing
John J. Monaco, PhD
Howard Hughes Medical Institute
University of Cincinnati
Monday, March 29, 1999
Symposium 3: Therapeutic Vaccines
Moderators:
Jacques Banchereau, PhD
Baylor Institute for Immunology Research
N. Regina Rabinovich, MD
National Institute of Allergy and Infectious Diseases
Dendritic Cells as Vectors for Tumor Vaccines
Jacques Banchereau, PhD
Baylor Institute for Immunology Research
Induction of Anti-Tumor Immunity by Chemokine-scFv Fusions in Murine B Cell Lymphomas
Arya Biragyn, PhD
National Cancer Institute
Characterization of Tumor Vaccines During Product Development
Raj K. Puri, MD, PhD
Food and Drug Administration
CpG Immunostimulatory Sequences for Therapeutic Vaccines
Arthur M. Krieg, MD
University of Iowa College of Medicine
Iowa City VA Medical Center
CpG ImmunoPharmaceuticals, Inc.
Submitted Presentations 3
Submitted Presentations 4
Submitted Presentations 5
Symposium 4: Genetic Determinants of Vaccine Immune Response
Moderators:
Janardan P. Pandey, PhD
Medical University of South Carolina
Gregory A. Poland, MD
Mayo Clinic and Foundation
An Overview of the Genetic Basis for Variations in the Immune Response to Vaccines
Gregory A. Poland, MD
Mayo Clinic and Foundation
Genetic Polymorphisms and Vaccine Immunity
Janardan P. Pandey, PhD
Medical University of South Carolina
Genetic Regulation of Immunoglobulin G Response to Pneumococcal Capsular Polysaccharide
Daniel M. Musher, MD
Houston VA Medical Center
Baylor College of Medicine
Poster Session and Reception
Tuesday, March 30, 1999

Symposium 5: Clinical Trials in Developing Countries: What Are the Issues?
Moderators:
José Esparza, MD, PhD
UNAIDS
Myron M. Levine, MD, DTPH
University of Maryland
Responsibilities of Sponsors After Successful Phase III Efficacy Trials
William P. Hausdorff, PhD
Wyeth-Lederle Vaccines
Post-Licensure Selective Vaccination and Surveillance Programs Can Provide Controlled Effectiveness Data
Rosanna Lagos, MD
Centro para Vacunas en Desarrollo, Chile
Hospital Roberto Del Rio
AIDS Exceptionalism in the Vaccine Arena: Additional Obstacles for HIV Vaccine Trials
José Esparza, MD, PhD
UNAIDS
Submitted Presentations 6
Symposium 6: Vaccines Against Candidate Bioterrorist Agents
Moderators:
Richard J. Duma, MD, PhD
Halifax Medical Center
Colonel Charles H. Hoke, Jr., MD, MC
U.S. Army Medical Research and Materiel Command
Overview of Potential Bioterrorist Biological Agents and Countermeasures
Lieutenant Colonel George W. Korch, Jr., PhD
U.S. Army Medical Research Institute of Infectious Diseases
Strategies for Vaccination Against Brucellosis Colonel David L. Hoover, MD
Walter Reed Army Institute of Research
Viral Agents and Countermeasures: Orthopoxviruses and Filoviruses
Peter B. Jahrling, PhD
U.S. Army Medical Research Institute of Infectious Diseases
Multi-Agent Vaccine Approaches for Infectious Agents
Jonathan F. Smith, PhD
U.S. Army Medical Research Institute of Infectious Diseases